![](https://investorshub.advfn.com/uicon/345750.png?cb=1538127739)
Monday, August 14, 2017 12:49:53 PM
http://www.owcpharma.com/our-leadership-team/
Dr. Stanley Hirsch – Chairman
Dr. Hirsch has extensive executive and board level experience for more than the past 25 years in private and publicly listed companies in biopharmaceutical and agricultural biotech industries, among others, including direct experience in raising capital and leading M&A activity together with multi-cultural management skills, having managed companies in Israel, Brazil, UK, China and the United States.
Dr. Hirsch served as Chairman of the Board of Directors of Foamix Pharmaceuticals Ltd., since 2016, and has also Group CEO of FuturaGene Limited and its predecessor company, FuturaGene Plc., since 2007.
Dr. Hirsch holds a D. Phil (1982) in Cell Biology and Immunolgy from Oxford University, UK. His educational experience also includes a B.Sc. degree with honors in Medical Biochemistry from the University of Capetown, South Africa (1979) among other academic honors and awards from Oxford University and University of Capetown
** Life Comes Down to a Few Short Moments **
This Could be one of Them !
FEATURED POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM